课题基金 / 基金详情

Chinese Red Yeast Rice Comparison to Lovastatin

Chinese Red Yeast Rice Comparison to Lovastatin
中国红曲米与洛伐他汀的比较
批准号：
6666250
负责人：
David Heber
金额：
$15.92万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2002
资助国家：
美国
项目状态：
已结题
起止时间：
2002-08-01 至 2003-07-31
来源：
https://reporter.nih.gov/project-details/6666250
关键词：
alternative medicine antiatherogenic agent antihypercholesterolemic agent clinical research drug discovery /isolation drug screening /evaluation genetic transcription genetically modified animals human subject laboratory mouse lovastatin male oxoacid lyase pharmacokinetics plant extracts rice tissue /cell culture yeasts

项目摘要

项目成果

David Heber的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Description: This project will evaluate the effect, on cholesterol biosynthesis and atherosclerotic lesion formation, of a mixture of monacolins isolated from a yeast fermented rice compared to Lovastatin. This will be accomplished by measuring up-regulation of HMG-COA gene transcription in HEPG2 cell constructs containing a luciferase reporter gene. A second end point will be the formation of atherosclerotic lesions and measuring blood cholesterol levels in ApoE knockout mice. The final study will assay the bioavailability of the mixture of monacolins from red yeast rice and of pure Lovastatin in human volunteers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of Alcohol-Associated Breast Cancer
ANTIOXIDANT AND ANGIOGENESIS EFFECTS OF GREEN TEA VS EGCG
A COMPARISON OF CHINESE RED YEAST RICE, A DIETARY SUPPLEMENT, TO LOVASTATIN I
Antioxidant /Angiogenesis Effects of Green Tea vs. EGCG